HBSS was replaced with 100 µL RPMI cell culture medium with 50 µM test compounds or 51 1% DMSO and incubated for 18 hours. DAPI was used for staining together with FITC-52 conjugated (Molecular Probes, Eugene, OR) purified serum IgG (MelonTM Gel IgG Spin 53
Purification Kit, Thermo Scientific, Il) from rabbit (Agrisera AB, Vännäs, Sweden) 54 immunized with formalin-fixed C. trachomatis L2 elementary bodies (15) . 55
Photomicrographs were generated (20x objective) and the number and area of Chlamydia 56 inclusions were determined (spot detection method) using ArrayScan VTi HCA Reader 57 (Thermo Fisher Scientific, Pittsburgh, PA). Artifacts and cellular toxicity were judged 58 visually. Six hits were excluded due to lack of dose-response or visible toxicity to the host 59 cells. Two potent hits were selected for further investigation: 1 and 2 (Table 1) . 60
Statistical molecular design (16), cherry-picking and chemical synthesis 61
(Supplemental Information) were used to select 28 and 44 analogs of 1 and 2 respectively. 62
Minimal inhibitory concentrations for C. trachomatis were determined for all compounds 63 (14). No potent analogs of 2 were identified (data available upon request) while analogs of 64 1 had a range of MIC values (Table 1) . Basic structure activity relationships for these 65 acylated sulfonamides demonstrated that the 5-methyl-3-isoxazolyl group is preferred over 66 the 3,4-dimethyl-5-isoxazolyl group cf. 1/19, 3/21, and 17/18. Truncation as in 7 and 10 or 67 introducing furane as in 8, 9, 22 and 25 were not beneficial. Compound 18 with a 68 benzothiophene-2-carboxamide group was the most potent inhibitor (MIC 6 µM). The anti-69 chlamydial effect was not caused by general toxicity to the host cells. HeLa cell viability 70 after 24-48 hours at 50 µM was >70 % for most compounds using the XTT Cell 71
Proliferation Assay Kit (ATCC) in uncolored DMEM (Table 2) . A para-halogenated aryl ring 72 in place of the isoxazole ring (26-29) was associated with cytotoxicity. 73 IC 50 in C. trachomatis and C. pneumoniae was determined for well-tolerated 74 compounds with MIC < 25 µM (Table 2) . C. pneumoniae T45 (17) values were derived from fitted curves (18). Dose-dependent activity was demonstrated on 78 C. trachomatis (Fig. S2, Fig. S3 ) and less prominent on C. pneumoniae, indicating lower 79 specificity in C. pneumoniae and differences in the molecular target. Compounds in Table  80 2 were bacterial as formation of infectious progeny was completely inhibited. No inclusions 81
were detected by immunostaining after passage of C. trachomatis grown 44 h with 25 µM 82 compound and harvested by freeze-thawing in sterile water. 83
All compounds follow the Lipinski's rules of five (19) with minor exceptions for 84 22 and 25. Even though the aqueous solubility was low, good oral absorption was 85 predicted in silico (20) mainly due to favorable cellular permeability (Table S2) Wallenberg foundation, and the Carl Trygger foundation for ME. 124 
